Empower Advisory Group LLC Has $620,000 Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Empower Advisory Group LLC reduced its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,615 shares of the company’s stock after selling 690 shares during the quarter. Empower Advisory Group LLC’s holdings in Doximity were worth $620,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. UMB Bank n.a. lifted its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the last quarter. Farther Finance Advisors LLC lifted its position in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc bought a new stake in shares of Doximity during the 3rd quarter worth $46,000. Covestor Ltd lifted its position in shares of Doximity by 441.9% during the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after buying an additional 1,370 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its position in shares of Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after buying an additional 384 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on DOCS. JPMorgan Chase & Co. increased their target price on Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. KeyCorp dropped their target price on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Mizuho raised their price objective on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $33.00 to $53.00 in a research report on Thursday, November 14th. Finally, Piper Sandler upgraded Doximity from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Doximity currently has an average rating of “Moderate Buy” and an average price target of $64.22.

Doximity Stock Performance

Shares of Doximity stock opened at $77.94 on Wednesday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The stock has a 50 day moving average price of $58.86 and a two-hundred day moving average price of $48.35. The stock has a market capitalization of $14.55 billion, a PE ratio of 77.94, a price-to-earnings-growth ratio of 4.61 and a beta of 1.39.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 37.40% of the stock is owned by insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.